The Score is a weekly review of the biggest stock moves and the news that drove them. Here is this week's installment: ...

Latest move to cut funding for vaccines is not down to US health secretary. It is part of Trump’s wider war on science.

Doting father-of-two John O'Neill from Althorne, Essex, had a one in 50,000 reaction to the AstraZeneca jab in May 2021 that ...

Federal regulators are caught between old-guard conservatives who demand continued mRNA funding, Rep. Massie's demand to ...

The federal government’s decision to slash $500 million in funding for mRNA vaccine research has sparked concern among health ...

So-called mRNA vaccines saved millions of lives during the COVID-19 pandemic — and now scientists are using that Nobel ...

With a 5.98% market share, India is the fourth-largest pharmaceutical supplier to the U.S., behind Ireland, Switzerland, and ...

GSK provides update on US settlement of CureVac/BioNTech mRNA patent litigation: London, UK Saturday, August 9, 2025, 10:00 Hrs [IST] GSK plc announces that, in connection with th ...

A value stock is generally a company that trades at a price lower than its fundamental value or what its performance suggests ...

Flutter Entertainment (FLTR) upped full-year guidance after a solid second quarter, with group revenue up 16 per cent to $4.2bn (£3.1bn) and adjusted Ebitda climbing 25 per cent to $919mn. Average ...

A gunman opened fire near CDC headquarters Friday, hitting at least four buildings on the agency’s campus in Atlanta and killing a Dekalb County police officer, authorities said. Media outlets have ...

The FDA has approved Pfizer's BCMAxCD3 bispecific antibody Elrexfio as another off-the-shelf treatment option for people with multiple myeloma who have exhausted at least four prior lines of ...